A. M. Jackson Et Al. , "Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.," European heart journal , vol.42, no.36, pp.3741-3752, 2021
Jackson, A. M. Et Al. 2021. Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.. European heart journal , vol.42, no.36 , 3741-3752.
Jackson, A. M., Jhund, P. S., Anand, I. S., Düngen, H., Lam, C. S. P., Lefkowitz, M. P., ... Linssen, G.(2021). Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.. European heart journal , vol.42, no.36, 3741-3752.
Jackson, Alice Et Al. "Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.," European heart journal , vol.42, no.36, 3741-3752, 2021
Jackson, Alice M. Et Al. "Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.." European heart journal , vol.42, no.36, pp.3741-3752, 2021
Jackson, A. M. Et Al. (2021) . "Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.." European heart journal , vol.42, no.36, pp.3741-3752.
@article{article, author={Alice M Jackson Et Al. }, title={Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.}, journal={European heart journal}, year=2021, pages={3741-3752} }